Aortic Aneurysm Devices Market Size Worth USD 8.41 Billion by 2034 | CAGR: 9.3%

The aortic aneurysm devices market size is expected to reach USD 8.41 billion by 2034, according to a new study by Polaris Market Research. The report “Aortic Aneurysm Devices Market Size, Share, Trend, Industry Analysis Report By Type (Thoracic Aortic Aneurysm, Abdominal Aortic Aneurysm), By Treatment, By Product, By End Use, By Region – Market Forecast, 2025–2034” gives a detailed insight into current market dynamics and provides analysis on future market growth.

The aortic aneurysm devices market encompasses medical technologies designed to manage and repair localized dilations in the aorta, primarily through endovascular and surgical interventions. This market is experiencing strong growth due to the increasing prevalence of cardiovascular diseases, aging demographics, and rising adoption of minimally invasive procedures. Innovations in stent graft design, including branched and fenestrated grafts, are enhancing treatment precision and enabling broader anatomical applicability. Demand is also driven by improved diagnostics and screening programs that detect aneurysms earlier, leading to timely therapeutic intervention. Growing physician preference for endovascular aneurysm repair (EVAR) over open surgery is further boosting procedural volumes and device utilization. Key industry trends include the integration of imaging-guided systems and the development of low-profile delivery catheters that support complex cases while reducing perioperative risk.

Do you have any questions? Would you like to request a sample or make an inquiry before purchasing this report? Simply click the link below: https://www.polarismarketresearch.com/industry-analysis/aortic-aneurysm-devices-market/request-for-sample

Advancements in biomaterials and device customization continue to evolve, addressing durability and long-term efficacy challenges. Increasing regulatory approvals for next-generation grafts and the expansion of reimbursement policies are opening new opportunities for both global manufacturers and emerging players. The market is also seeing broader acceptance of hybrid techniques, combining open and endovascular approaches, especially for anatomically complex aneurysms. Collaboration between device manufacturers and clinical researchers is accelerating innovation and clinical evidence generation, supporting confidence in device safety and performance. The landscape is shifting toward personalized, image-driven repair solutions supported by real-time analytics, which are expected to shape the next phase of competitive advantage.

Top of FormAortic Aneurysm Devices Market Report Highlights

• By type, the abdominal aortic aneurysm segment accounted for ~71% of the revenue share. Abdominal aortic aneurysms are more frequently diagnosed compared to thoracic types, particularly in older adults and individuals suffering from chronic cardiovascular conditions.
• Based on treatment, in 2024, the endovascular aneurysm repair segment accounted for ~75% of the revenue share due to its preferred approach for treating aortic aneurysms because of its minimally invasive nature, lower surgical risk, and shorter recovery time.
• In 2024, the North America aortic aneurysm devices market accounted for ~46% of the revenue share due to high diagnosis rates, advanced healthcare infrastructure, and widespread adoption of endovascular procedures.
• The Asia Pacific aortic aneurysm devices market is expected to register the highest CAGR of 11.35% from 2025 to 2034 due to improving access to healthcare services and the growing presence of specialized cardiovascular centers.
• A few global key players include Medtronic, Endologix LLC, Gore Medical (W. L. Gore & Associates), MicroPort Scientific Corporation, Cook, JOTEC (Cryolife, Inc.), Cardinal Health, Terumo Corporation, and Lombard Medical.

Polaris Market Research has segmented the aortic aneurysm devices market report on the basis of type, treatment, product, end use, and region:

By Type Outlook (Revenue USD Billion, 2020–2034)

• Thoracic Aortic Aneurysm (TAA)
• Abdominal Aortic Aneurysm (AAA)

By Treatment Outlook (Revenue USD Billion, 2020–2034)

• Open Surgical Repair (OSR)
• Endovascular Aneurysm Repair (EVAR)

By Product Outlook (Revenue USD Billion, 2020–2034)

• Stent Grafts
• Catheters

By End Use Outlook (Revenue USD Billion, 2020–2034)

• Hospitals
• Ambulatory Surgery Centers
• Clinics

By Regional Outlook (Revenue USD Billion, 2020–2034)

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Vietnam
  • Australia
  • Rest of Asia Pacific
• Latin America
  • Argentina
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa
  • Rest of Middle East & Africa